As of Feb 12
| -0.26 / -5.16%|
The 6 analysts offering 12-month price forecasts for GenMark Diagnostics Inc have a median target of 9.00, with a high estimate of 15.00 and a low estimate of 7.25. The median estimate represents a +88.28% increase from the last price of 4.78.
The current consensus among 7 polled investment analysts is to Buy stock in GenMark Diagnostics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.